Drug intelligence / Profile preview

zoster vaccine live (Beijing Chaoyang District Centre for Disease Control and Prevention)

Development stage
Approved
Lead developer
Beijing Chaoyang District Center for Disease Control and Prevention
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

A live attenuated vaccine developed by the Beijing Chaoyang District Centre for Disease Control and Prevention for the prevention of herpes zoster (shingles) in adults aged 50 years and older. The vaccine utilizes a weakened form of the Varicella Zoster Virus (VZV) to stimulate a robust immune response, specifically targeting the decline in cell-mediated immunity associated with aging. By boosting VZV-specific T-cell levels, the vaccine aims to prevent the reactivation of latent VZV from the sensory ganglia. Clinical development has progressed through Phase 1 and Phase 2 trials in China, evaluating the safety and immunogenicity of various viral titers ranging from 4.3 to 5.0 lgPFU.

Other names
live attenuated herpes zoster vaccinezoster vaccine live

Beyond the preview

Go deeper on zoster vaccine live (Beijing Chaoyang District Centre for Disease Control and Prevention).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zoster vaccine live (Beijing Chaoyang District Centre for Disease Control and Prevention).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call